mRNA Vaccines mRNA Technology Historical Vaccine Development Safety Concerns Infectious Disease Research HIV Vaccine Trials Manufacturing Innovations
Kennedy Jr. said data show mRNA vaccines offer limited protection against respiratory infections, prompting a reallocation of nearly $500 million to more established vaccine technologies.